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Introduction
In general terms we all use the word “stress” to describe our
discomfort in coping with challenges of daily life. This is
mostly related to our subjective perceptions of workload
and/or other unexpected physical or mental efforts we are
exposed to. The term is derived from the concept of stress as
a reaction to internal and external stimuli requiring acute or
chronic adaptations, as introduced by Hans Selye in the
second half of the last century [1–3].
In 1998 on a WHO conference on stress a more compre-
hensive definition of the term was provided:
“Stress may be defined as a mechanism of acute and
chronic adaptation necessary for evolution and
survival. The integrated stress response is part of the
homoeostatic balance, and dysfunction of such
response may contribute to disease. Alternations of
the endocrine, neural and immune responses to stress
are involved both in etiology and the pathophysiology
of the most common health problems in modern
society.” (World Health Organization_WHO/RPS/
98.3).
In a biological sense stress is a two-edged sword repre-
senting a positive side (eustress) and a negative side (dis-
tress). On one hand, eustress helps to deal with challenges
of daily life and disease, and it is also a driver of evolution
and development. On the other hand, a chronic response to
stress with chronic activation of the endocrine stress axis
will trigger and contribute to metabolic and cardiovascular
diseases [4, 5].
Endocrine and neural responses to stress have been well-
defined and involve an activation of both the hypothalamic-
pituitary-adrenal axis (HPA) and the sympathoadrenal sys-
tem. A wide variety of external and internal stimuli,
including inflammation, infection, as well as physical and
mental stressors induces the release of corticotropin-
releasing hormone (CRH) from the paraventricular
nucleus (PVN) of the hypothalamus. CRH in turn is both a
central activator of the HPA axis, as well as the sym-
pathoadrenal system, since CRH mediates the release of
adrenocorticotropic hormone (ACTH) from the pituitary
and hence adrenocortical glucocorticoids as well as the
release of epinephrine from the adrenal medulla [4]. In
addition to CRH as a main regulator of the HPA axis there
are numerous CRH and ACTH-independent factors,
including neuropeptides, cytokines, the microbiota-gut-
brain axis [6], and even bacterial and viral pathogens that
are capable of activating the release of adrenal stress ster-
oids [7].
Finally, central activation of the autonomic nervous
system will lead to an acute activation of the adrenal
medulla by the splanchnic nerves triggering the release of
epinephrine and other neuropeptides. Interestingly,
splanchnic nerve stimulation will also provoke the release
of adrenal glucocorticoids and mineralocorticoids, which is
mediated in a paracrine way by the released catecholamines
[8].
Thus, there is a complex network of neuronal and cel-
lular interactions within the end organ of the endocrine and
neuroendocrine stress system. It is no coincidence that the
adrenal gland combines the steroid-producing adrenal cor-
tex and the catecholamine-producing adrenal medulla under
a common organ capsule. In fact, there is an active cellular
and functional interaction of cortical and chromaffin cells
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within the gland. Whereas adrenocortical glucocorticoids
are required for the biosynthesis of adrenomedullary epi-
nephrine, catecholamines regulate the release of steroids
and the cellular function of the adrenal cortex [9]. Fur-
thermore, patients with disorders of the adrenal cortex such
as Addison’s disease or congenital adrenal hyperplasia
display a dysfunction of the adrenal medulla resulting in an
impaired stress response [10–12].
In addition to the cellular crosstalk between the two
endocrine cell systems in the adrenal there is an important
role for the vasculature and the immune system. Nearly
each adrenal cell is in close proximity to endothelial cells
and the gland receives ten times more blood than expected
from its size [9]. Therefore, the intact physical and bio-
chemical communication between vascular and endocrine
cells is critical for the functional integrity and adaptation to
stress of the entire gland, as vascular vulnerability may lead
to ruptures, hemorrhage and adrenal failure with life-
threatening consequences for the patient [13, 14]. Similarly,
intact interactions with the systemic and resident immune
cells are critical for proper functioning of the adrenal and its
ability to cope with the increased stress of inflammation and
sepsis [13, 14].
In addition to this complex interplay of cellular and
neuronal networks in mounting and maintaining an ade-
quate adrenal stress response, regulation of the secretion of
peripheral and central stress hormones is under strict cir-
cadian and ultradian control [15]. Thus, the entire endocrine
stress system is embedded in an even more complex and not
fully explored cybernetic model of positive and negative
feedback regulations, which mature postnatally to become
fully functional only after puberty.
This leads to the obvious question of how stress in early
life may shape the development and maturation of the major
cellular response elements including the HPA axis. Before
we try to explore this intriguing question we should reflect
on what is known-up to now on the role of the classical
stress hormones on the regulation of stem cells in general.
Role of stress steroids on progenitor/stem cell
populations
Progenitor and stem cell populations are both required for the
successful homeostasis and adaptation of most tissues.
Human hematopoietic stem and progenitor cells provide
lifelong production of mature blood cells dependent on the
changing requirements of each individual. Therefore, hema-
topoiesis is a cellular process defined by a clear balance of
self-renewal and commitment to differentiation. Hemato-
poietic progenitors are also able to transdifferentiate into non-
hematopoietic cells and exhibit overlapping genetic programs
with mesenchymal and neural stem cells (NSCs). Importantly,
neuronal stem cells in mice have been reported to be sensitive
to steroid-induced cell death (apoptosis) through glucocorti-
coid receptor (GR) signaling [16], providing a model for the
sensitivity of neuronal stem cells to metabolic cellular turn-
over and/or cellular loss induced by stress.
Interestingly, we have identified CRH1 and CRH2 receptors
not only in NSCs but also in hematopoietic stem cells
(HSCs) [17]. CRH receptors are involved in the systemic
stress response and intriguingly CRH receptor expression is
increased among immature hematopoietic progenitors but
not in fully differentiated blood cells. Stimulation with CRH
decreases intracellular cAMP demonstrating active signal-
ing of this central stress hormone in HSCs [17]. Recently,
the CNS has been shown to regulate embryonic HSCs via
the HPA axis, as GR activation leads to HSC expansion
while GR loss reduces HSC formation [18]. Likewise
chronic stress exposures also activate HSC formation [19].
While, we are only beginning to understand the role of
stress hormones on HSCs, their roles on NSCs and neuro-
genesis have been explored more comprehensively. Most
importantly stress hormones exert a differential effect on
neurogenesis depending on age, time, location, and nature of
the exposure. Conditions that strongly elevate CRH, ACTH
and glucocorticoids, such as physical activity, enriched
environmental housing, or mental stress induce proliferation
and survival of newborn neurons and promote neurogenesis
[20]. Conversely, chronic endogenous or pharmacological
exposure of NSCs to glucocorticoids has been clearly asso-
ciated with reduced neurogenesis [20]. This has been linked to
the activation of GRs or to changes in the expression of genes
associated with cellular senescence [21–23]. Why the acti-
vation of the HPA axis leads to enhanced neurogenesis in
some instances yet the loss of neural stem cells in others has
not been fully understood [20].
Proliferating neuronal progenitors express higher levels
of CRH receptors and are enhanced in the human fetal brain
[24]. Moreover, CRH-deficient mice show reduced pro-
liferation and increased apoptosis among neural progenitors.
Thus, it has been suggested that CRH, as the major mediator
of the adaptive response to stressors, could reverse damaging
effects of glucocorticoids on stem/progenitor cells [24].
If CRH could reverse the damaging effects of gluco-
corticoids it may be assumed that the negative feedback on
CRH with elevated glucocorticoid levels contributes to the
reduction of neurogenesis observed during chronic stress. In
addition, we and others have shown that during the acute
and chronic stress of inflammation and sepsis but also in
mental and metabolic disorders, several extra-hypothalamic
and extra-pituitary factors including cytokines, pathogens,
adipokines, growth factors, inflammatory lipids, morpho-
gens, catecholamines, and neuropeptides can stimulate
adrenal glucocorticoid release [7, 9]. Consequently, the
neuroprotective effect of CRH may get lost during both
acute and chronic stress. Another explanation may relate to
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the pattern of glucocorticoid secretion during stress as it has
been demonstrated that daily oscillations in glucocorticoids
control both proliferation and function of the circadian
clock in the hippocampus [25]. Indeed, clock genes play a
crucial role in neuronal differentiation of adult NSCs [26].
Thus, glucocorticoid regulation seems to be crucial for
the maintenance of adult neurogenesis and the adaptation of
NSC proliferation to environmental changes. As circadian
and ultradian glucocorticoid rhythmicity is impaired during
severe stress it may provide further explanation for the
negative effect of glucocorticoids on neurogenesis under
these conditions [15].
However, chronic activation of the endocrine stress
system does not only impair neural stem cells but also other
stem cell populations. For example, chronic restraint, an
established model to induce chronic physiological stress in
mice, leads to elevated levels of glucocorticoids and
decreases the function and repair potential of mesenchymal
stem cells [27]. Specifically, chronic stress inhibited their
differentiation into myofibroblasts, hampering repair effi-
ciency in a model of liver injury [27].
Considering that we are now beginning to understand the
wide range of actions of stress hormones on stem and
progenitor cells, the enormous clinical and therapeutic
implications become obvious. Reassessing our way of
thinking and our current strategy of glucocorticoid repla-
cement regimens in those with chronic adrenal failure, we
can avoid damaging effects on early cellular development,
repair and regeneration by regulating cell death pathways
even beyond signaling of apoptosis [28]. On the other hand
we may have the opportunity to exploit the great potential
of stress hormones in a precise and individualized manner
for improving cell renewal and regenerative therapies.
However, before we discuss a new view on translational
and clinical concepts it will be worthwhile to address how
mechanistically stress induces stem cells in the endocrine
organs producing the stress hormones. If stress in early life
is able to direct stem cell fate and lineage commitment this
can have major implications in responding to and coping
with disease during adulthood. It will also add an entirely
new level of complexity to the link of mental and physical
stressors related to our capacity of self-renewal, cell death,
resilience, cell repair, and regeneration. This in turn may
have direct implications for multiple new lines of evidence
regarding disease etiopathogenesis, particularly mechan-
isms by which early abnormalities in stress hormone reg-
ulation may lead to common diseases in later life.
Stem cells induced by stress
An intricate network of morphogens and growth factors and
a defined combinatorial code of transcription factors direct
the hypothalamic, pituitary, and adrenal progenitor cells to
form the mature HPA axis [29, 30]. External and internal
stressors from the first day of life influence the process of
cell differentiation of stem and progenitor cells in the HPA
axis to form the fully functional endocrine stress system.
Chronic stress in a variable stress model, which includes
unpredictable stressors such as crowding, isolation, cage tilt
and light-dark changes, stimulates presynaptic and post-
synaptic modifications in the paraventricular nucleus of the
hypothalamus that are in accordance with increased HPA
axis drive [31]. Unpredictable stress activates inter-
connected cortical, hypothalamic and brainstem nuclei
suggesting a recruited circuitry mediating chronic drive of
brain stress effector systems [31].
Previously, we isolated, characterized, and differentiated
chromaffin stem/progenitor cells from the human, bovine,
and murine adrenal medulla [32–34]. Primary cells cultured
as spheres from human medulla express progenitor markers
including Nestin, NOTCH1 and SOX2 and are able to
differentiate both into distinct neuron-like cell types and
into endocrine chromaffin cells [32, 33]. In mice, we have
identified a defined pool of glial-like Nestin-expressing
progenitor cells that are multipotent and able to differentiate
into both chromaffin cells and neurons both in vitro and
in vivo [35]. Interestingly, immobilization stress promotes
the differentiation of these Nestin-positive progenitor cells
into chromaffin cells, and has also been shown to alter the
expression of catecholamine-producing enzymes and the
release of catecholamines [35]. Hence, stress induces both a
molecular and cellular adaptation by recruiting new
catecholamine-producing cells from the stem cell pool to
cope with increased demand [36, 37].
More importantly, Nestin-expressing progenitors are not
only located in the adrenal medulla but also in the adrenal
cortex. Likewise metabolic and physical stressors seem to
induce mature steroid-producing cells from this pool [38].
Tissue-specific stem/progenitor cells in the adult pituitary
gland have been identified using genetic tracing experi-
ments [39]. Cells expressing the transcription factor SOX2,
a sub-population of which also express Nestin, are
capable of self-renewal and the direct generation of new
hormone-producing cells during postnatal life as well as
in vitro [39–41]. In fact, this population can become
mobilized and differentiate into the appropriate endocrine
cell type in response to physiological stress [32]. In addition
to their contribution to the physiological maintenance of the
adult pituitary, we have demonstrated that these SOX2-
expressing stem/progenitor cells can be involved in the
induction of pituitary tumors [40, 41].
Major developmental signaling pathways are active in
stem cells of the pituitary [30], and similar mechanism hold
true for the peripheral effector organ of the HPA axis, the
adrenal gland, in both the steroid-producing adrenal cortex
and the catecholamine-producing adrenal medulla. This
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may suggest a uniform and coordinated signature and pro-
gramming within the entire endocrine stress axis, thereby,
hinting at common or shared pathways in generating stress-
inducible stem cells (SISCs) shaping the entire adaptive
stress response in the HPA axis and beyond. These obser-
vations also emphasize the possibility of common regula-
tion of cellular responses within the HPA axis and
sympathoadrenal system related to stress adaption. (Fig. 1)
How is the concept of stress-inducible stem cells
(SISCs) changing our view of metabolic and mental
disease?
Chronic stress conditions and the inability to cope with
stress lead both to increased vulnerability and aggravation
of metabolic and mental disease [42]. For example, leptin
and other adipocyte-derived peptides including adipocyte-
derived CRH are closely linked to the endocrine stress
system [43–47] and high levels of glucocorticoids produced
by the adrenal cortex of subjects exposed to stress lead to
reduced neurogenesis. In turn, impaired neurogenesis in the
CNS is closely linked to psychiatric disease, such as
depression and posttraumatic stress disorders and metabolic
disorders [15, 48, 49] as angiotensin-sensitive neurons
expressing CRH coordinate neuroendocrine, cardiovascular,
and behavioral responses to stress [48].
Furthermore, adipocyte-derived mesenchymal stem cells
from patients with metabolic syndrome are defective in
differentiation, angiogenesis, motility, multipotency, as well
as metabolism and immunomodulation [50]. This may
suggest that a pro-inflammatory environment, with the
endocrine stress axis promoting obesity through priming
and dysregulation of SISCs at multiple levels (including the
brain, endocrine, and adipose issues).
As already mentioned, hematopoietic stem and progenitor
cells are affected by CRH and glucocorticoids [17, 18].
Therefore, the early stress activation of SISCs in hematopoi-
esis will induce inflammatory leukocytes contributing to the
pathogenesis of metabolic-vascular disease [19].
Also in the pancreas a functional CRH receptor system is
present. A brain-pancreatic islet axis is mediated by CRH and
other hypothalamic peptides on beta cells [51]. Stress has also
been shown to affect stem/progenitor cells in islets. This may
suggest that the entire stress-regulation of stem cells in the
endocrine pancreas will shape and modify lifelong islet cell
mass and therefore capacity for insulin secretion [52].
Finally, glucocorticoids induce a reduction in proliferation
of hypothalamic neural stem cells that can have major con-
sequences in adulthood on the development of both mental
and metabolic diseases. Hyperactivation of the HPA axis has
been clearly linked to the early development of metabolic
disease and to the severity of its cardiovascular complications.
Fig. 1 Stem cells from a range of
tissues are influenced by
different kinds of stress in both a
positive (eustress) and negative
(distress) manner giving rise to
positive/negative metabolic
memory
Stress-inducible-stem cells: a new view on endocrine, metabolic and mental disease? 5
Glucocorticoids promote fat cell maturation, obesity, and
insulin resistance while fat cell mass correlates with both
glucocorticoid and aldosterone levels [53]. Also, mesenchy-
mal stem cells isolated from metabolic syndrome and type 2
diabetes patients exhibit cellular dysfunction based on
increased oxidative stress and autophagy [54]. Malnutrition,
high fat diets, maternal immune activation, immobility and
neglect, environmental toxins, and many other adverse events
are well-known risk factors for mental and metabolic disease
but also autoimmune and malignant disease will induce an
early dysregulation of these intricate networks of SISCs.
This means that many longstanding observations, such as
the link between early life abuse-associated trauma and
subsequent metabolic risk factors/diseases [55] may now
become clearer following our better understanding of the
concepts of SISCs.
Twenty years after the first description of stem cells, we
are able to comprehend the fact that their stress-induction
represents a general concept of adaptation to the challenges
of daily life and coping with disease.
Similar to the discovery and characterization of a specific
stem cell pool in cancer, nature might have created a distinct
subset of stem and progenitor cells that are inducible and
regulated by stress. As an ancient and positive mechanism
to drive evolution and development, early priming of a pool
of SISCs, be it beneficial or detrimental, will later define
healthy living or morbidity with premature death due to
chronic and acute disease.
Stress-induction drives migration of stem cells and may
explain complete or incomplete organ formation or min-
gling of cellular components. It may explain aberrant
expression of peptide receptors with autonomous tumor
formation in endocrine tissues contributing to metabolic and
mental disease. In patients with both these diseases together,
adrenal hyperplastic and/or adenomatous adrenals with
manifest or subclinical hypercortisolism have been
observed [56]. This may explain impairment of the normal
circadian or ultradian rhythms of hormone release, leading
to a vicious cycle of maladaptation and stress hormone
exposure with all its metabolic and central consequences
[15]. Such mechanisms may form a basis for the concept of
a “negative metabolic memory“ contributing to irreversible
long-term damage e.g., of cardiovascular disease in patients
at the beginning of the metabolic disease process [57].
The observation that endocrine disruptors induce per-
turbations in the endoplasmic reticulum and mitochondria
of human pluripotent stem cell derivatives reveals the long
lasting and severe consequences of these obesogenic
endocrine disrupting chemicals on the developing gut
endocrine and neuroendocrine system [58]. Therefore,
unavoidable environmental stressors can induce alterations
in the microbiome, innate immune functions and metabolic
and neural functions based on early modifications of SISCs.
How should the concept of stress-inducible stem
cells affect our clinical strategies for the diagnosis
and treatment of metabolic and mental disease?
First of all it will require the development of more appro-
priate cellular models to study and characterize further the
properties of the various subsets of SISCs. An interesting
approach to analyze obesity and gene-environment inter-
actions has been the generation of human-induced plur-
ipotent stem cells from individuals with normal body mass
index and from patients with morbid obesity (BMI >50)
[59]. In this study stem cells from obese individuals were
differentiated into neurons capable of secreting hypotha-
lamic neuropeptides. This revealed functional defects in
cells from morbidly obese patients including altered hor-
mone signaling of ghrelin and leptin and dysregulated
endoplasmic reticulum stress pathways [59].
Recently, we generated human-induced steroidogenic cells
from fibroblasts, blood, and urine-derived cells employing
forced expression of steroidogenic factor-1 and activation of
the protein kinase A (PKA) and luteinizing hormone-
releasing hormone (LHRH) pathways [60].
These models will allow researchers to better define the
mechanisms of stress hormones and other stressors in
reprogramming of progenitor cells. Furthermore, chimeric
models, genome engineering and gene editing, cell encap-
sulation, microfluidics and organs-on-a-chip will permit the
elucidation of mechanisms of stress induction of stem cells,
their common pathways and relevance to chronic disease
[61–69]. Regarding current treatment of metabolic and
mental disease, a serious reflection on the concept of a
distinct subset of SISCs in the human body will necessitate
immediate changes in the management of these disorders:
(1) We will have to reemphasize the enormous signifi-
cance of adverse effects and stressors in early life for
chronic diseases in adulthood, as childhood and
adolescence represent the most dynamic periods of
our development. Social chaos and family traumas
can no longer be viewed as mere economic or socio-
ethical problems for society; they are agents of disease
causation with potentially serious and irreversible
long-term health problems.
(2) We will have to redesign prevention programs
considering the interplay of stress, metabolic regen-
eration, and cell renewal.
(3) The current treatment regimens of glucocorticoids
have to be adapted and tailored to avoid improper
triggering and dysregulation of the stress-inducible
stem cell pool.
(4) Current and novel medications for the treatment of
metabolic and mental diseases should be tested for their
effect on stress-induction of stem cells in a precise and
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individualized manner. Such over-arching effects on
SISCs may be important for determining the relative
lifetime benefits of various treatment options.
(5) Regenerative therapies should be developed to exploit
the benefit of eustress induction of stem cells for efficient
self-renewal, repair, and recovery from chronic ailments.
Conclusion
As the field of stem cell research is entering adulthood and as
its potential for clinical applications and even for cures
becomes more evident, it is the right time to embrace the new
concept of stress-inducible stem cells. We propose that the
effects of stress on young stem/progenitor cells during the
early stages of postnatal development may predispose to adult
disease. Preventing such negative effects may reduce the
incidence or delay the onset of common conditions, with
significant impact on welfare. Preserving the functionality of
sparse stem/progenitor cell populations could have further-
reaching consequences on human health than anticipated. As
with other aspects of human health, the maxima of ‘preven-
tion is better than cure’ may also apply to the stem cell field.
We anticipate that more profound knowledge of the
mechanism underlying the interactions between stressors and
stem/progenitor cells will yield novel preventative approaches.
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